Insights into disease and pharmacotherapy knowledge of Alzheimer's disease among community pharmacists: a cross-sectional study
dc.authorid | Anmar Al-Taie / 0000-0002-2183-6830 | en_US |
dc.authorscopusid | Anmar Al-Taie / 57221579036 | en_US |
dc.authorwosid | Anmar Al-Taie / DTF-7591-2022 | en_US |
dc.contributor.author | Al-Taie, Anmar | |
dc.contributor.author | Yılmaz, Zekiye K. | |
dc.contributor.author | Dahman, Hasan | |
dc.contributor.author | Yardımcı, Turay | |
dc.date.accessioned | 2022-11-12T06:51:22Z | |
dc.date.available | 2022-11-12T06:51:22Z | |
dc.date.issued | 2022 | en_US |
dc.department | İstinye Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü | en_US |
dc.description.abstract | Objective To assess the knowledge level and awareness of Alzheimer's disease, including knowledge about the disease, pharmacotherapy, provision of patient education and associated factors among community pharmacists across Turkey and Northern Cyprus. Methods This was a descriptive, cross-sectional study conducted among community pharmacists working in Turkey (Group A) and Northern Cyprus (Group B). Disease and pharmacotherapy knowledge of AD were assessed using AD Knowledge Scale (ADKS), and drug treatment (KADT) scale, respectively. Results Both groups reported a moderate level of knowledge of AD, especially medically-oriented domains, with no significant difference regarding the mean ADKS domains (18.8 +/- 2.8 vs. 18.9 +/- 3.4; p = .98). Nevertheless, participants from both groups reported a good level of KADT knowledge about AD treatment (p = .03). Group A reported a statistically significant higher level of knowledge about drug interactions compared with Group B (54.6% vs. 45.8%; p = .01), and knowledge about proper information (79.6% vs. 31.8%; p = .02). There was a statistically significant KADT difference correlated with gender, those having a Master degree, more than 5 years of work experience, and those taking AD training courses. Conclusion There is still a lack of knowledge regarding AD reported by moderate ADKS score, especially in medically-oriented domains, which creates a barrier to early provision of care and preventing AD, noted with no difference among community pharmacists across Turkey and Northern Cyprus. | en_US |
dc.identifier.citation | Al-Taie, A., Yilmaz, Z. K., Dahmanv, H., & Yardimci, T. (2022). Insights into disease and pharmacotherapy knowledge of Alzheimer’s disease among community pharmacists: a cross-sectional study. Current Medical Research and Opinion, (just-accepted), 1-23. | en_US |
dc.identifier.doi | 10.1080/03007995.2022.2129802 | en_US |
dc.identifier.scopus | 2-s2.0-85139911288 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.uri | https://doi.org/10.1080/03007995.2022.2129802 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/3333 | |
dc.identifier.wos | WOS:000865692300001 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Al-Taie, Anmar | |
dc.language.iso | en | en_US |
dc.publisher | TAYLOR & FRANCIS LTD | en_US |
dc.relation.ispartof | CURRENT MEDICAL RESEARCH AND OPINION | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Alzheimer's Disease | en_US |
dc.subject | Community Pharmacists | en_US |
dc.subject | Geriatrics | en_US |
dc.subject | Knowledge | en_US |
dc.subject | Turkey | en_US |
dc.title | Insights into disease and pharmacotherapy knowledge of Alzheimer's disease among community pharmacists: a cross-sectional study | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- Insights into disease and pharmacotherapy knowledge of Alzheimer s disease among community pharmacists a cross sectional study.pdf
- Boyut:
- 1.5 MB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text
Lisans paketi
1 - 1 / 1
Küçük Resim Yok
- İsim:
- license.txt
- Boyut:
- 1.44 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama: